Di-tert-butyl (R)-2-(aminomethyl)piperazine-1,4-dicarboxylate, 97%, 100mg

BMPyrr TFSI, 25 g, >=99%, glass packaging

5-Chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole, 95.0%, 10g

1,3-Dioxan-2-one>98.0%(GC)5g

N-(4-Bromophenyl)pyridine-2-carboxamide, 97%, 5g

1-(5-Fluoro-2-methoxybenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

(3R,4R)-1-BOC-3-AMINO-4-FLUOROPYRROLIDINE, 95.0%, 100mg

2-(furan-2-yl)-5-(piperidin-3-yl)-1,3,4-oxadiazole, 95.0%, 250mg

(R)-3-(3-Fluoro-phenyl)-5-hydroxymethyl-oxazolidin-2-one, 95.0%, 250mg

2-(1-[(TERT-BUTOXY)CARBONYL]-3-HYDROXYPIPERIDIN-3-YL)ACETIC ACID, 95.0%, 1g

4'-amino-3',5'-dichloroacetophenone, 97.0%, 500g

6-BROMO-2-CHLORO-3-NITROQUINOLINE, 95.0%, 100mg

3-(Thiophen-2-ylmethoxy)benzaldehyde, 98%, 500mg